Psychological factors that influence decision making about prophylactic surgery
暂无分享,去创建一个
[1] C. Spielberger. State‐Trait Anxiety Inventory , 2010 .
[2] Suzanne M. Miller,et al. Enhanced Counseling for Women Undergoing BRCA1/2 Testing: Impact on Subsequent Decision Making About Risk Reduction Behaviors , 2005, Health education & behavior : the official publication of the Society for Public Health Education.
[3] M. Brännström,et al. Differences in aspects of personality and sexuality between perimenopausal women making different choices regarding prophylactic oophorectomy at elective hysterectomy , 2005, Acta obstetricia et gynecologica Scandinavica.
[4] R. Myers,et al. Decision counseling in cancer prevention and control. , 2005, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[5] H. Valdimarsdottir,et al. Decision making and decision support for hereditary breast-ovarian cancer susceptibility. , 2005, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[6] Terry Connolly,et al. Regret in cancer-related decisions. , 2005, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[7] Y. Cheung,et al. Acceptance of Prophylactic Surgery and Chemoprevention of Cancer in Singapore – , 2005 .
[8] J. Husted,et al. Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[9] G. Glendon,et al. A multicenter study of supportive‐expressive group therapy for women with BRCA1/BRCA2 mutations , 2004, Cancer.
[10] L. Hartmann,et al. Surgical risk reduction: prophylactic salpingo-oophorectomy and prophylactic mastectomy. , 2004, American journal of obstetrics and gynecology.
[11] W. Daal,et al. Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] P. Butow,et al. Short- and Long-Term Impact of Receiving Genetic Mutation Results in Women at Increased Risk for Hereditary Breast Cancer , 2004, Journal of Genetic Counseling.
[13] Susan L Neuhausen,et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] A. Fiander,et al. An exploratory qualitative study of women's perceptions of risk management options for familial ovarian cancer: implications for informed decision making. , 2004, Gynecologic oncology.
[15] W. Foulkes,et al. Prevention and genetic testing for breast cancer: variations in medical decisions. , 2004, Social science & medicine.
[16] P. Hall,et al. Preoperative psychological reactions and quality of life among women with an increased risk of breast cancer who are considering a prophylactic mastectomy. , 2004, European journal of cancer.
[17] J. Oosterwijk,et al. Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer , 2004, American journal of medical genetics. Part A.
[18] P. Butow,et al. Communication and information-giving in high-risk breast cancer consultations: influence on patient outcomes , 2004, British Journal of Cancer.
[19] S. Narod,et al. Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy , 2004, Psycho-oncology.
[20] Suzanne M. Miller,et al. Psychosocial correlates of intention to undergo prophylactic oophorectomy among women with a family history of ovarian cancer. , 2003, Preventive medicine.
[21] C. Isaacs,et al. Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] J. Klijn,et al. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] P. Butow,et al. Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer. , 2003, Journal of women's health.
[24] W. Otten,et al. Genetic counselling and the intention to undergo prophylactic mastectomy: effects of a breast cancer risk assessment , 2003, British Journal of Cancer.
[25] L. Fallowfield,et al. A qualitative study looking at the psychosocial implications of bilateral prophylactic mastectomy. , 2003, Breast.
[26] R. J. Cersosimo. Tamoxifen for Prevention of Breast Cancer , 2003, The Annals of pharmacotherapy.
[27] Mark E. Robson,et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation , 2002 .
[28] P. Butow,et al. Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: a prospective study. , 2002, Gynecologic oncology.
[29] Susan L Neuhausen,et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. , 2002, The New England journal of medicine.
[30] J. Klijn,et al. One Year Follow-Up of Women Opting for Presymptomatic Testing for BRCA1 and BRCA2: Emotional Impact of the Test Outcome and Decisions on Risk Management (Surveillance or Prophylactic Surgery) , 2002, Breast Cancer Research and Treatment.
[31] R. L. Baldwin,et al. Cancer incidence in a population of Jewish women at risk of ovarian cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] J Dowie,et al. Development and preliminary evaluation of a clinical guidance programme for the decision about prophylactic oophorectomy in women undergoing a hysterectomy , 2002, Quality & safety in health care.
[33] Suzanne M. Miller,et al. The Influence of Attentional Style and Risk Perceptions on Intentions to Undergo Prophylactic Oophorectomy Among First-Degree Relatives , 2002 .
[34] A. Cull,et al. Deciding about prophylactic oophorectomy: what is important to women at increased risk of ovarian cancer? , 2001, Preventive medicine.
[35] N. Lindberg,et al. Anxiety and compliance among women at high risk for breast cancer , 2001, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.
[36] I. Jacobs,et al. Surveillance or surgery? A description of the factors that influence high risk premenopausal women's decisions about prophylactic oophorectomy , 2001, Journal of medical genetics.
[37] W. Foulkes,et al. Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another , 2001, Cancer.
[38] J. Klijn,et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. , 2001, The New England journal of medicine.
[39] A. Cull,et al. Prophylactic oophorectomy versus screening: psychosocial outcomes in women at increased risk of ovarian cancer , 2001, Psycho-oncology.
[40] S. Mahon. Factors affecting genetic testing and decisions about prophylactic surgery. , 2001, Clinical journal of oncology nursing.
[41] E. Warner,et al. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[42] M. Daly,et al. Anxiety/uncertainty reduction as a motivation for interest in prophylactic oophorectomy in women with a family history of ovarian cancer. , 2001, Journal of women's health & gender-based medicine.
[43] J. Klijn,et al. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[44] E. Swisher,et al. Prophylactic oophorectomy and ovarian cancer surveillance. Patient perceptions and satisfaction. , 2001, The Journal of reproductive medicine.
[45] W. Foulkes,et al. Variation in prophylactic surgery decisions , 2000, The Lancet.
[46] M. Robson,et al. Screening for ovarian cancer: what we know, what we need to know. , 2000, Oncology.
[47] M. Watson,et al. Understanding the experience of prophylactic bilateral mastectomy: a qualitative study of ten women , 2000, Psycho-oncology.
[48] L. Andrews,et al. Psychological impact of prophylactic oophorectomy in women at increased risk for ovarian cancer , 2000, Psycho-oncology.
[49] N. Hallowell. A qualitative study of the information needs of high‐risk women undergoing prophylactic oophorectomy , 2000, Psycho-oncology.
[50] T. Sellers,et al. Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. , 2000, JAMA.
[51] R. Croyle,et al. Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. , 2000, Preventive medicine.
[52] P. Butow,et al. Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[53] P. Devilee,et al. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation , 2000, The Lancet.
[54] K. Sandelin,et al. Initial experiences of women from hereditary breast cancer families after bilateral prophylactic mastectomy: a retrospective study. , 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[55] T. Rebbeck,et al. Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[56] P. Borgen,et al. Women’s Regrets After Bilateral Prophylactic Mastectomy , 2000, Annals of Surgical Oncology.
[57] Suzanne M. Miller,et al. Decision making about prophylactic oophorectomy among at-risk women: psychological influences and implications. , 1999, Gynecologic oncology.
[58] C K Redmond,et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.
[59] P. Butow,et al. Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer. , 1999, Gynecologic oncology.
[60] O. Olopade,et al. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. , 1999, Journal of the National Cancer Institute.
[61] P. Borgen,et al. Issues of Regret in Women With Contralateral Prophylactic Mastectomies , 1999, Annals of Surgical Oncology.
[62] J. Benkendorf,et al. Bilateral prophylactic mastectomy decision making: A vignette study. , 1999, Preventive medicine.
[63] P. Stalmeier,et al. Evaluation of a Shared Decision Making Program for Women Suspected to Have a Genetic Predisposition to Breast Cancer , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.
[64] P. Stalmeier,et al. Assessment of the Time-tradeoff Val ues for Prophylactic Mastectomy of Women with a Suspected Genetic Predisposition to Breast Cancer , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.
[65] M. Shepard. Tamoxifen and Breast Cancer Prevention , 1998 .
[66] P. Boyle,et al. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women , 1998, The Lancet.
[67] M. Piver,et al. Extraovarian primary peritoneal carcinoma. , 1998, Oncology.
[68] N. Hallowell. ‘You don’t want to lose your ovaries because you think ‘I might become a man' ’. Women's perceptions of prophylactic surgery as a cancer risk management option , 1998, Psycho-oncology.
[69] J Chang-Claude,et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.
[70] L. Temple,et al. Is incidental prophylactic oophorectomy an acceptable means to reduce the incidence of ovarian cancer? , 1997, American journal of surgery.
[71] K M Kuntz,et al. Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. , 1997, The New England journal of medicine.
[72] B. Littenberg,et al. The effect of an educational intervention on the perceived risk of breast cancer , 1996, Journal of General Internal Medicine.
[73] K. Helzlsouer,et al. Predictors of and satisfaction with bilateral prophylactic mastectomy. , 1995, Preventive medicine.
[74] A. Kurjak,et al. Ovarian cancer screening , 1994, Current opinion in obstetrics & gynecology.
[75] M. Piver,et al. Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the gilda radner familial ovarian cancer registry , 1993, Cancer.
[76] K. Lu,et al. Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation , 2005 .
[77] S. Narod,et al. Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer , 2004, Familial Cancer.
[78] I. Jacobs,et al. Ovarian cancer screening , 2002, Hospital medicine.
[79] Anne,et al. BREAST CANCER AFTER PROPHYLACTIC BILATERAL MASTECTOMY IN WOMEN WITH A BRCA 1 OR BRCA 2 MUTATION , 2001 .
[80] L. Fallowfield,et al. questionnaires and semistructured interviews mastectomy : prospective study using The psychosocial impact of bilateral prophylactic , 2001 .
[81] E. Swisher,et al. Prophylactic oophorectomy and ovarian cancer surveillance , 2001 .
[82] P. Oefner,et al. Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Austrian Hereditary Breast and Ovarian Cancer Group. , 2000, British journal of cancer.
[83] D. Easton,et al. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. , 1995, American journal of human genetics.